North American Interventional Cardiology & Peripheral Vascular Devices Market - Forecast to 2018

North American Interventional Cardiology & Peripheral Vascular Devices Market - Forecast to 2018

Regular price $5,650.00 Sale

Published on Jun 05, 2014 - 245 pages

North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018

The North American interventional cardiology and peripheral vascular devices market is expected to grow at a CAGR of 2.9% from 2013 to 2018. Both, the lower volume of coronary angioplasty procedures and the increasing prevalence rate of peripheral artery diseases have impacted the market significantly.

Amongst all the product segments, bioabsorbable stents, retrievable inferior vena cava filters, and diagnostic catheters (intravascular ultrasound and optical coherence tomography catheters) markets are identified as the high growth segments in the North American interventional cardiology and peripheral vascular devices market. Better diagnosis of thrombus using IVUS and OCT catheters is expected to drive the diagnostic catheters market; whereas, lesser risk of long-term post surgical complications in DVT/PE treatments will encourage faster adoption of the retrievable inferior vena cava filters in the coming years. The bioabsorbable stents are still not available for clinical usage in the U.S. However, bioabsorbable stents are available on a special access basis by Health Canada.

The usage factors of different surgical instruments were the major hindrances while deriving the market size of the corresponding surgical devices. This is primarily due to the availability of various surgical instruments for the treatment of similar cardiac ailments. For instance, coronary angioplasty can be performed through plain balloon catheter, stent, and/or a combination of stent and catheter, based on patients' cardiac health.

The study on the North American interventional cardiology and peripheral vascular devices market captures an exhaustive list of surgical devices which are used in various types of angioplasty procedures, deep vein thrombosis, endovascular aneurysm repairing, and chronic total occlusion (CTO) treatment procedures. This research illustrates specific driving and restraining factors in the U.S. and Canadian markets; furthermore, it identifies the high-growth regions with regard to the interventional cardiology and peripheral vascular devices market. This extensive study provides an analytical comparison of the key players in terms of their segmental revenue and related portfolio and their respective market shares in the U.S. and Canadian market spaces in 2013. In a nutshell, this research intends to capture all facets of the North American interventional cardiology and peripheral vascular devices market to put forward approachable market solutions for leading players as well as new entrants.



Table of Contents

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 MARKET SCOPE
1.6 RESEARCH METHODOLOGY
1.6.1 MARKET SIZE ESTIMATION
1.6.2 KEY DATA POINTS FROM PRIMARY SOURCES
1.6.3 KEY DATA FROM SECONDARY SOURCES
1.6.4 MARKET SHARE ANALYSIS
1.6.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 PREMIUM INSIGHTS
3.1 U.S. & CANADIAN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET
3.2 MARKET DYNAMICS
3.3 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE
3.4 ANGIOPLASTY STENTS & CATHETERS MARKET
3.5 MARKET SHARE ANALYSIS
4 MARKET OVERVIEW
4.1 NORTH AMERICAN DEMOGRAPHICS
4.2 INTERVENTIONAL PROCEDURES
4.2.1 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
4.2.2 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA)
4.2.3 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFT
4.2.4 THROMBOEMBOLISM
4.3 MARKET SEGMENTATION
4.4 MARKET DYNAMICS
4.4.1 DRIVERS
4.4.1.1 Increasing peripheral interventional procedures to drive the market
4.4.1.2 Double-digit growth in aging population to spur the market growth
4.4.1.3 Significant increase in PCI centers in the U.S. and long waiting periods for care in Canada encourage patients to opt for MIS procedures
4.4.1.4 New CPT codes to boost complex stenting procedures
4.4.2 RESTRAINTS & THREATS
4.4.2.1 Declining coronary angioplasty procedures in the U.S. to restrict technology adoption
4.4.2.2 Conventional first-level medication treatments to limit the market scope
4.4.3 OPPORTUNITIES
4.4.3.1 Rising importance of better diagnosis will lead to increase in adoption of IVUS and OCT catheters
4.4.3.2 Retrievable IVC filters market to witness the highest CAGR in PAD treatment devices market
4.4.3.3 Bioabsorbable stents-a promising future for the North American interventional cardiology market
4.5 MARKET SHARE ANALYSIS
5 ANGIOPLASTY BALLOONS
5.1 INTRODUCTION
5.2 OLD/NORMAL BALLOONS
5.2.1 INCREASING ADOPTION OF NEW TECHNOLOGIES IMPEDES ADOPTION RATE
5.3 CUTTING BALLOONS
5.4 SCORING BALLOONS
5.5 DRUG-ELUTING BALLOONS
6 ANGIOPLASTY STENTS
6.1 INTRODUCTION
6.1.1 INTRODUCTION OF SELF-EXPANDABLE STENTS IN 2012 IN CANADA
6.2 DRUG-ELUTING STENTS
6.2.1 DRUG-ELUTING STENTS TO WITNESS A SLUGGISH GROWTH
6.3 BARE-METAL STENTS
6.3.1 BARE-METAL STENTS TO SHOW SLUGGISH GROWTH OWING TO SEVERE SIDE-EFFECTS
6.4 BIOABSORBABLE STENTS
6.4.1 FEWER POST-SURGICAL SIDE-EFFECTS TO ENCOURAGE FASTER ADOPTION
7 CATHETERS MARKET
7.1 INTRODUCTION
7.2 GUIDING CATHETERS
7.3 ANGIOGRAPHY CATHETERS
7.4 INTRAVASCULAR ULTRASOUND (IVUS) CATHETERS
7.5 OPTICAL COHERENCE TOMOGRAPHY (OCT) CATHETERS
7.5.1 ADOPTION OF OCT CATHETERS TO HELP IN EASY DIAGNOSIS OF CALCIFIED LESIONS
8 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET
8.1 INTRODUCTION
8.2 ABDOMINAL AORTIC ANEURYSM (AAA) STENT GRAFTS
8.3 THORACIC AORTIC ANEURYSM (TAA) STENT GRAFTS
9 INFERIOR VENA CAVA (IVC) FILTERS MARKET
9.1 INTRODUCTION
9.2 RETRIEVABLE INFERIOR VENA CAVA FILTERS
9.3 PERMANENT INFERIOR VENA CAVA FILTERS
10 PLAQUE MODIFICATION DEVICES MARKET
10.1 INTRODUCTION
10.2 THROMBECTOMY DEVICES
10.3 ATHERECTOMY DEVICES
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET
11.1 INTRODUCTION
11.2 EMBOLIC PROTECTION DEVICES (EPD)
11.3 CHRONIC TOTAL OCCLUSION (CTO) DEVICES
12 ACCESSORY DEVICES MARKET
12.1 INTRODUCTION
12.2 VASCULAR CLOSURE DEVICES
12.3 INTRODUCER SHEATHS
12.4 GUIDE WIRES
12.5 BALLOON INFLATION DEVICES
13 GEOGRAPHIC ANALYSIS
13.1 INTRODUCTION
13.1.1 U.S.
13.1.1.1 Over 20% growth in PCI facilities to drive technology adoption